SARMs & Hair Loss – How to Avoid it

SARMs hair loss is one of the most frequently reported cosmetic side effects among users of selective androgen receptor modulators. While SARMs were designed to selectively target muscle and bone tissue rather than hair follicles and prostate, their indirect effects on hormonal balance — particularly sex hormone-binding globulin (SHBG) and dihydrotestosterone (DHT) — mean that certain compounds carry meaningful hair loss risk, especially in genetically predisposed individuals.

The relationship between SARMs and hair loss is compound-specific rather than class-wide. Some SARMs suppress SHBG aggressively enough to elevate free DHT levels and trigger accelerated shedding, while others have minimal hormonal impact and are considered hair-neutral. Understanding which compounds fall into each category is essential for individuals concerned about hair retention during a cycle.

How SARMs Cause Hair Loss

SARMs do not directly convert to DHT the way anabolic steroids do. Their mechanism of hair loss operates indirectly through hormonal suppression pathways.

The primary mechanism involves SHBG (sex hormone-binding globulin) suppression. SHBG binds to both testosterone and DHT in the bloodstream, effectively neutralizing their androgenic activity. Research indicates that SHBG binds to DHT with approximately 1.3 times greater affinity than to testosterone, making it particularly important for regulating DHT’s effects on hair follicles.

When a SARM suppresses SHBG production, the pool of unbound (free) DHT increases. This elevated free DHT then interacts with androgen receptors in the scalp’s hair follicles, accelerating miniaturization in individuals with genetic sensitivity to androgenic alopecia.

The severity depends on three factors: genetic predisposition to androgenic alopecia, the degree of SHBG suppression caused by the specific SARM, and the dosage used. SARMs hair shedding varies widely between individuals — those with no family history of male pattern baldness may experience no hair changes even with suppressive compounds.

SARMs That Cause Hair Loss

RAD 140 (Testolone)

RAD 140 hair loss is the most commonly reported among all SARMs. Testolone is one of the most suppressive compounds in the SARM category, producing significant SHBG reduction even at moderate doses. The hormonal disruption from RAD 140 is substantial enough that the majority of users with genetic hair loss predisposition report noticeable shedding during a cycle.

At doses above 10 mg daily, RAD 140 hair loss becomes increasingly likely. The shedding typically begins during the first 2-4 weeks of a cycle as SHBG levels decline and free DHT rises.

S23

S23 is the most suppressive SARM available and carries significant hair loss risk. Its androgenic activity approaches that of low-dose anabolic steroids, and the degree of natural testosterone suppression it produces makes hair shedding a common side effect.

YK-11

YK-11 functions as both a SARM and a myostatin inhibitor. Its impact on hair is less predictable than RAD 140 but carries moderate risk due to its hormonal effects. Limited research data makes the exact hair loss profile difficult to characterize.

SARMs That Don’t Cause Hair Loss

Ostarine (MK 2866)

Ostarine is the mildest commonly used SARM and produces minimal SHBG suppression at standard doses (10-25 mg daily). SARMs hair loss from Ostarine would require doses well above 50 mg daily — far beyond typical protocols. For individuals concerned about hair retention, Ostarine represents the lowest-risk option among actual SARMs.

MK 677 (Ibutamoren)

MK 677 is a growth hormone secretagogue, not a SARM. It does not bind androgen receptors, does not suppress testosterone, and does not affect SHBG levels. Because it stimulates growth hormone production, MK 677 may actually support hair health by promoting cellular regeneration and reducing cortisol-related stress effects. Some individuals use MK 677 alongside more suppressive compounds specifically to offset potential hair effects.

Cardarine and Stenabolic

Neither Cardarine (GW 501516) nor Stenabolic (SR9009) are SARMs despite frequent categorization alongside them. Both are non-hormonal compounds that operate through entirely different mechanisms — Cardarine through PPARdelta receptor activation and Stenabolic through Rev-Erb protein modulation. Neither compound has any interaction with testosterone, SHBG, or DHT, making hair loss from these compounds essentially impossible.

How to Minimize Hair Loss on SARMs

Compound Selection

The most effective strategy for avoiding SARMs and hair loss is choosing compounds with lower SHBG suppression profiles. Replacing RAD 140 with Ostarine for cutting cycles, or using non-hormonal compounds like Cardarine for endurance benefits, eliminates the primary hair loss mechanism entirely.

Dose Management

Hair loss severity correlates directly with dosage. Staying at the lower end of recommended dose ranges reduces SHBG suppression and limits the free DHT increase that triggers shedding. Running shorter cycles (6-8 weeks rather than 10-12) also reduces cumulative hormonal impact.

Ketoconazole Shampoo

Ketoconazole-based shampoos (Nizoral or equivalents) applied 2-3 times weekly have demonstrated anti-androgenic activity at the scalp level. The compound reduces local DHT activity in hair follicles, providing a topical defense against androgen-mediated miniaturization.

Product Quality

Low-quality or contaminated research chemicals introduce unpredictable variables. Products contaminated with prohormones or other androgenic compounds produce hormonal effects beyond what the labeled SARM should cause, potentially triggering hair loss from a compound that would otherwise be hair-neutral. Purchasing from vendors that provide third-party Certificates of Analysis (COAs) reduces this risk.

Stress Management

Telogen effluvium — stress-induced hair shedding — is a common confounding factor. Anxiety about potential hair loss during a cycle can itself trigger shedding through cortisol elevation and disruption of the hair growth cycle. Distinguishing between hormonal (androgenic) shedding and stress-related shedding requires attention to the pattern: androgenic hair loss follows the male pattern baldness distribution (temples, crown), while stress shedding is diffuse.

Hair Recovery After SARMs

SARMs hair loss is generally reversible. Once a cycle ends and natural testosterone production recovers — either naturally or through post-cycle therapy — SHBG levels return to baseline, free DHT normalizes, and hair growth typically resumes within 2-4 months.

Permanent SARMs hair shedding is unlikely unless the individual was already in the early stages of genetic androgenic alopecia that the SARM accelerated. In those cases, the compound may have triggered loss that would have eventually occurred regardless — it accelerated the timeline rather than causing a new condition.